Skip to main content

MoneyWorks4Me

Panacea Biotec informs about press release

28 Mar 2016 Evaluate

Panacea Biotec has informed about a Press Release dated March 28, 2016 titled ‘Panacea Biotec Launches - CABAPAN, A Cost Effective product for the treatment of metastatic Castration Resistant Prostrate Cancer (mCRPC)’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1371.20
Cipla 1409.00
Lupin 1990.00
Zydus Lifesciences 1195.00
View more..